Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

aTYR PHARMA (ATYR) EBIT Margin (2019 - 2025)

Historic EBIT Margin for aTYR PHARMA (ATYR) over the last 6 years, with Q3 2025 value amounting to 14076.32%.

  • aTYR PHARMA's EBIT Margin changed N/A to 14076.32% in Q3 2025 from the same period last year, while for Sep 2025 it was 41395.26%, marking a year-over-year decrease of 124365400.0%. This contributed to the annual value of 28899.57% for FY2024, which is 133417800.0% down from last year.
  • Latest data reveals that aTYR PHARMA reported EBIT Margin of 14076.32% as of Q3 2025.
  • Over the past 5 years, aTYR PHARMA's EBIT Margin peaked at 76.55% during Q4 2022, and registered a low of 14076.32% during Q3 2025.
  • For the 4-year period, aTYR PHARMA's EBIT Margin averaged around 6201.42%, with its median value being 5326.4% (2024).